CDH1 Gene Gastric Cancer Hereditary Diffuse Genetic Test
At DNA Labs UAE, we offer the CDH1 gene gastric cancer hereditary diffuse genetic test. This test helps in identifying individuals who may have an increased risk of developing hereditary diffuse gastric cancer (HDGC).
Test Details
The CDH1 gene is responsible for making a protein called E-cadherin, which plays a crucial role in maintaining the normal structure and function of epithelial cells in the body. Mutations in the CDH1 gene can lead to HDGC, a rare form of stomach cancer that tends to occur at a young age and has a high risk of spreading throughout the stomach and other organs.
The CDH1 gene gastric cancer hereditary diffuse genetic test utilizes Next-Generation Sequencing (NGS) technology. NGS genetic testing is a type of advanced genetic test that allows for the simultaneous analysis of multiple genes. In the case of CDH1 gene testing, NGS can identify mutations or changes in the CDH1 gene that may be associated with an increased risk of developing hereditary diffuse gastric cancer.
Components and Price
The CDH1 gene gastric cancer hereditary diffuse genetic test is priced at 4400.0 AED. The test can be performed using either blood or extracted DNA samples. Alternatively, one drop of blood on an FTA card can also be used for the test.
Report Delivery and Method
After the sample is collected, the report delivery typically takes 3 to 4 weeks. The NGS technology is employed for the analysis of the CDH1 gene.
Test Type and Doctor
The CDH1 gene gastric cancer hereditary diffuse genetic test falls under the category of cancer genetic testing. This test is usually recommended and supervised by an oncologist.
Test Department
The CDH1 gene gastric cancer hereditary diffuse genetic test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the CDH1 gene gastric cancer hereditary diffuse genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with CDH1 gene gastric cancer hereditary diffuse genetic test gene CDH1.
Importance of Genetic Testing for CDH1 Gene Mutations
Genetic testing for CDH1 gene mutations is particularly recommended for individuals with a strong family history of gastric cancer, especially cases of early-onset or diffuse gastric cancer. This information can be valuable in guiding medical management and screening recommendations for individuals and their families.
It is essential to consult a healthcare provider or genetic counselor before deciding to undergo genetic testing. They can assess an individual’s personal and family history and provide appropriate recommendations.
Test Name | CDH1 Gene Gastric cancer hereditary diffuse Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CDH1 Gene Gastric cancer, hereditary diffuse NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDH1 Gene Gastric cancer, hereditary diffuse NGS Genetic DNA Test gene CDH1 |
Test Details |
CDH1 gene is a gene that provides instructions for making a protein called E-cadherin. This protein is responsible for maintaining the normal structure and function of epithelial cells, which line the organs and tissues in the body. Mutations in the CDH1 gene can lead to a condition called hereditary diffuse gastric cancer (HDGC). HDGC is a rare form of stomach cancer that tends to occur at a young age and has a high risk of spreading throughout the stomach and to other organs. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CDH1 gene testing, NGS can identify mutations or changes in the CDH1 gene that may be associated with an increased risk of developing hereditary diffuse gastric cancer. NGS genetic testing for CDH1 gene mutations can be used to identify individuals who may have an increased risk of developing hereditary diffuse gastric cancer. This information can be helpful in guiding medical management and screening recommendations for individuals and their families. It’s important to note that genetic testing for CDH1 gene mutations is typically recommended for individuals with a strong family history of gastric cancer, particularly cases of early-onset or diffuse gastric cancer. The decision to undergo genetic testing should be made in consultation with a healthcare provider or genetic counselor who can assess an individual’s personal and family history and provide appropriate recommendations. |